Saudi Food and Drug Authority warns of painkiller risks, urges safe use

The Saudi Food and Drug Authority has emphasized that the proper use of painkillers begins with following medical instructions and guidelines, adhering strictly to recommended doses and not exceeding them.

In a statement on X, the authority warned that using painkillers for extended periods or in high doses can pose serious health risks, including liver damage or failure, stomach ulcers and bleeding, kidney impairment, high blood pressure, and drug toxicity.

The authority advised several safety measures, such as checking the active ingredient to avoid taking two medications with different brand names but the same active component, sticking to the prescribed dose and duration by following the package insert and the instructions of a doctor or pharmacist, and never exceeding the recommended dose.

It also stressed the importance of consulting a doctor or pharmacist, especially for the elderly, pregnant women, or those with heart, liver, or kidney conditions, or high blood pressure.

The authority cited examples of painkillers, including non-steroidal anti-inflammatory drugs (such as ibuprofen and Rofenac) used for dental pain, joint pain, and inflammation, and paracetamol (acetaminophen) products like Panadol and Fevadol, which are used to reduce fever and relieve headaches and pain.

View the post on X